Fig. 6

Comparison of PFS between anlotinib monotherapy and combination therapy in first-and second-line treatment versus third-line and beyond treatment
Comparison of PFS between anlotinib monotherapy and combination therapy in first-and second-line treatment versus third-line and beyond treatment